Castle Biosciences lays out new diagnostic innovation roadmap at Future Biotech Expo

Castle Biosciences lays out new diagnostic innovation roadmap at Future Biotech Expo
Castle Biosciences innovation at expo

Castle Biosciences took the stage at the Future Biotech Expo 2026, where Dr. Hillary Caruso presented new directions in precision healthcare.

Dr. Caruso, a leading scientist with Castle Biosciences, outlined the growing influence of advanced diagnostics, data applications, and emerging healthcare technologies. The session focused on integrating innovation and next-generation diagnostic tools to further personalize patient treatment. Industry attendees engaged on the potential for these technologies to reshape healthcare delivery. Details are being clarified.

The company previously detailed its growth and expansion through Phoenix bioscience alliances, according to its COO Kristen Oelschlager. In 2024, Castle Biosciences also secured approval for a dual listing on Nasdaq Texas. These developments have contributed to the organization’s evolving footprint in the biotech sector.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.